Skip to main content
. 2022 Dec 9;13:1046130. doi: 10.3389/fendo.2022.1046130

Figure 5.

Figure 5

Effects of semaglutide on liver metabolomics in HFD-induced NAFLD model. (A) PCA was utilized to analyze the metabolites from NFD and HFD-fed rats with and without semaglutide treatment for 24 weeks; (B, C) OPLS-DA was utilized to analyze the metabolites between NCD and HFD group or HFD and HFD+sema group; PLS-DA, partial least squares discriminant analysis; OPLS-DA, orthogonal partial least squares discriminant analysis; NAFLD, non-alcoholic fatty liver disease.